Beclomethasone Dipropionate in Participants At Least 12 Years Old With Persistent Asthma

Study Title
A Safety and Efficacy Study of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Participants >=12 Years Old With Persistent Asthma
Teva Identifier
BDB-AS-301 | 2013-003397-27
ClinicalTrials.gov Identifier
NCT02031640
Study Status
Completed
Trial Condition(s)
Asthma
Interventions
Drug: Beclomethasone dipropionate | Drug: Placebo | Drug: Albuterol/salbutamol

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Print

Click for participation criteria and map of study locations


Key Participation Requirements

Gender
Female, Male
Age Range
12 Years and older
Trial Duration
12/01/2013 - 12/01/2014
Phase
Phase 3

Study Type

Interventional